99
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue

, , , , , , & show all
Pages 121-129 | Published online: 23 Jul 2018

References

  • MoelansCBde WegerRAVan der WallEvan DiestPJCurrent technologies for HER2 testing in breast cancerCrit Rev Oncol Hematol201180338039221273092
  • Piccart-GebhartMJProcterMLeyland-JonesBHerceptin Adjuvant (HERA) Trial Study TeamTrastuzumab after adjuvant chemotherapy in HER2-positive breast cancerN Engl J Med2005353161659167216236737
  • WolffACHammondMEHicksDGAmerican Society of Clinical OncologyCollege of American PathologistsRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateJ Clin Oncol201331313997401324101045
  • PressMFHungGGodolphinWSlamonDJSensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expressionCancer Res19945410277127777909495
  • ThomsonTAHayesMMSpinelliJJHER-2/neu in breast cancer: inter-observer variability and performance of immunohistochemistry with four antibodies compared with fluorescent in situ hybridizationMod Pathol200114111079108611706067
  • NittaHHauss-WegrzyniakBLehrkampMDevelopment of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH)Diagn Pathol200834118945356
  • VargaZNoskeARamachCPadbergBMochHAssessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control studyBMC Cancer20131361524377754
  • LehmannUGlöcknerSKleebergerWvon WasielewskiHFKreipeHDetection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reactionAm J Pathol200015661855186410854209
  • GjerdrumLMSorensenBSKjeldsenESorensenFBNexoEHamilton-DutoitSReal-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysisJ Mol Diagn200461425114736826
  • ChariyalertsakSPurisaWVinyuvatSHer-2/neu amplification determined by real-time quantitative PCR and its association with clinical outcome of breast cancer in ThailandAsian Pac J Cancer Prev20111271703170622126548
  • JanbabaiGOladiZFarazmandfarTTaghvaeiTNaghshvarFThe prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative real-time PCRJ Cancer Res Clin Oncol2015141111945195225820598
  • SandersRHuggettJFBushellCACowenSScottDJFoyCAEvaluation of digital PCR for absolute DNA quantificationAnal Chem201183176474648421446772
  • DongLMengYSuiZWangJWuLFuBComparison of four digital PCR platforms for accurate quantification of DNA copy number of a certified plasmid DNA reference materialSci Rep201551317426302947
  • LiKDoDHegerichPAccurate quantification of HER2 gene amplification using QuantStudio™ 3D digital PCR systemAACR Annual MeetingApril 5–9, 2014San Diego, CA Poster #1521
  • HeHJAlmeidaJLLundSPSteffenCRChoquetteSColeKDDevelopment of NIST standard reference material 2373: genomic DNA standards for HER2 measurementsBiomol Detect Quantif201681827335805
  • ParthSShivaMNidhiSBhaviniSMandavaRComparative detection of hepatitis B viral load using chip based QuantStudio 3D digital PCR and COBAS Taqman real-time PCR systemInt J Appl Biol Pharm201782714
  • ColpaertCSalgadoRBelgian guidelines for Her2/neu testing in breast cancerBelgian J Med Oncol2007112229
  • ArnouldLRogerPMacgroganGAccuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH)Mod Pathol201225567568222222637
  • MansfieldASSukovWREckel-PassowJEComparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancerAm J Clin Pathol2013139214415023355198
  • BarlettJMIbrahimMJasaniBExternal quality assurance of HER2 FISH and ISH testing: three years of the UK National External Quality Assurance SchemeAm J Clin Pathol2009131110611119095573
  • BelgraderPTannerSCReganJFKoehlerRHindsonBJBrownASDroplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissueClin Chem201359699199423358413
  • WhaleASHuggettJFCowenSComparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variationNucleic Acids Res20124011e8222373922